Home / Overcoming Regulatory Blockers through an Expert MDR Assessment

Overcoming Regulatory Blockers through an Expert MDR Assessment

Regulatory Questions Delayed Clinical and Product Plans

MDR Assessment needed: A digital health startup was preparing for clinical studies and early traction but faced uncertainty around software qualification as a medical device under MDR. They needed clarity fast, as it was blocking their product roadmap and limiting conversations with partners and investors. With multiple user groups, diagnostic features and sensor integrations, the classification was unclear and misclassification could be costly.

Their internal team had deep domain expertise but no experience with MDR or IEC 82304-1. They didn’t know what evidence was required to justify the software’s intended use, or which changes would trigger recertification. To move forward, they needed a clear MDR assessment from experts who could quickly identify risk factors, scope out necessary updates, and give them a documented basis for strategic decisions.

Our Approach: A Fast Lightweight MDR Assessment with Actionable Outputs

We conducted a targeted MDR assessment to identify key regulatory blockers and clarify what the company needed to change or document to align with MDR expectations. The aim was to allow the client to continue with clinical planning and partner discussions without committing fully to certification yet.

In two structured sessions, we analysed their product's intended use, user flows and system architecture. We mapped this against MDR requirements and guided the team through risk classification, software safety class, clinical evidence strategy, and notified body expectations. The result was a focused action plan tailored to their specific product and business model.

What We Delivered: Clarity, Strategy and a Practical Action Plan

"Illustration of a person holding a checklist that outlines steps completed during an MDR Assessment. The document includes tasks like reviewing the app prototype, defining MDR criteria, classifying risks, and presenting compliant pathways."

Instead of a long report, we delivered a focused MDR summary document outlining regulatory risks, required next steps and recommended documentation priorities. This gave the team and investors clarity on where they stood and what is realistic.

Our assessment provided a strategic overview of how to approach MDR without overengineering the product or wasting resources. The team could prioritise the right activities, allocate responsibilities and communicate confidently with clinical and funding partners.

At a Glance, What was Delivered:

"Icon symbolizing innovation and achievement within the diagnosis app, with a lightbulb representing ideas and a checkmark denoting successful results."

MDR Compliance Roadmap

Clear next steps and required documents for MDR alignment

Less Regulatory Uncertainty

Identification of gaps and risks early in the development process

"Icon representing user interaction with an AI health app."

Improved Investor Readiness

Regulatory strategy aligned with product & funding milestones

"Icon representing a mobile app development process with code brackets on a smartphone screen, symbolizing the technical aspect of a diagnosis app."

Lean Documentation Plan

Documentation tailored to product scope and risk level

Cross-Team Alignment

Shared awareness of regulatory duties across team roles

How the Digital Health Team Moves Forward Now

With the MDR assessment complete, the team now has a clear regulatory baseline and practical steps toward alignment. The findings help clarify what needs to be done before moving to clinical validation or submitting for CE marking.

They are currently prioritising technical documentation, refining their development processes and mapping out remaining regulatory requirements. The goal: bring their digital health product to market in a compliant, auditable and scalable way.